Intervein Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-07-2024
- Paid Up Capital ₹ 1.50 M
as on 17-07-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 17-07-2024
- Revenue -56.20%
(FY 2023)
- Profit -165.74%
(FY 2023)
- Ebitda -144.97%
(FY 2023)
- Net Worth -278.57%
(FY 2023)
- Total Assets -21.06%
(FY 2023)
About Intervein Laboratories
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.00 Cr.
Sagi Rao and Shivprakash Chinnappa serve as directors at the Company.
- CIN/LLPIN
U85110GJ2005PTC046803
- Company No.
046803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Intervein Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagi Rao  | Additional Director | Current | |
| Shivprakash Chinnappa | Director | 21-Sep-2005 | Current |
Financial Performance of Intervein Laboratories.
Intervein Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 56.2% decrease. The company also saw a substantial fall in profitability, with a 165.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 278.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intervein Laboratories?
In 2023, Intervein Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avance Phytotherapies Private LimitedActive 20 years 7 monthsShivprakash Chinnappa is a mutual person
Novelgenix Therapeutics Private LimitedActive 13 years 6 monthsShivprakash Chinnappa is a mutual person
Synchron Research Services Private LimitedActive 26 years 6 monthsShivprakash Chinnappa is a mutual person
Rain( Recruitment Agency For Indian Nurses) India Private LimitedActive 15 years 9 monthsSagi Rao is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2017 | ₹8.53 M | Open |
Corporation Bank Creation Date: 25 Apr 2012 | ₹0.75 M | Open |
Corporation Bank Creation Date: 21 Feb 2006 | ₹0.74 M | Open |
How Many Employees Work at Intervein Laboratories?
Unlock and access historical data on people associated with Intervein Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intervein Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intervein Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
